USPTO serial 88380917
AMBAR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 17, 2020
- Examiner
- KHAN, ASMAT A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with AMBAR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $2,600
Owner
GRIFOLS WORLDWIDE OPERATIONS LIMITED
Dublin 22, IE
Other trademarks owned by GRIFOLS WORLDWIDE OPERATIONS LIMITED
GRIFOLS WORLDWIDE OPERATIONS LIMITED
Dublin 22, IE
Other trademarks owned by GRIFOLS WORLDWIDE OPERATIONS LIMITED
GRIFOLS WORLDWIDE OPERATIONS LIMITED
Dublin 22, IE
Other trademarks owned by GRIFOLS WORLDWIDE OPERATIONS LIMITED
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ashly I. Boesche
Ashly I. Boesche PATTISHALL, MCAULIFFE, NEWBURY, HILLIARD200 S. WACKER DRIVE, SUITE 2900CHICAGO, IL 60606UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for Plasma Protein Replacement Therapies; Diagnostic preparations for medical purposes, namely, plasma-derived protein preparation for medical purposes; Biological preparations for use with Plasma Protein Replacement Therapies for the treatment of Alzheimer's disease and other cognitive disorders | ACTIVE | — |
| 009 | Computer programs and software recorded and downloadable for use in database management in the field of Plasma Protein Replacement Therapies; Electronic publications, both downloadable and recorded on computer media, in the nature of journals and reports from scientific congresses and clinical trial studies in the field of Plasma Protein Replacement Therapies | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, medical apparatus and instruments for the treatment of Alzheimer's disease and other cognitive disorders | ACTIVE | — |
| 016 | Printed publications in the nature of journals, reports from scientific congresses, and educational and teaching materials in the field of Plasma Protein Replacement Therapies; Printed promotional materials, namely, pamphlets, brochures and reports from clinical trial studies in the field of medical treatments for Alzheimer's disease; Books in the field of Plasma Protein Replacement Therapies; Booklets in the field of Plasma Protein Replacement Therapies; Catalogues in the field of Plasma Protein Replacement Therapies; Diagrams for illustrating plasma protein replacement therapy; Printed flyers in the field of Plasma Protein Replacement Therapies; Printed forms; Graphic prints and graphic art reproductions and representations; Newsletters about Plasma Protein Replacement Therapies; Pictures | ACTIVE | — |
| 035 | Compilation of information into computer databases; Compilation of statistics; Computerized file management; Distribution of samples for publicity purposes; Document reproduction; Organization of exhibitions for commercial and advertising purposes; Organization of trade fairs for commercial and advertising purposes; Outdoor advertising; Radio and television advertising; Wholesale and retail store services in shops and on-line via global computer networks featuring pharmaceutical, biological and diagnostic preparations for medical purposes, computer programs and software recorded or downloadable, electronic publications, medical apparatus and instruments, printed publications, teaching materials, books, booklets, catalogues, diagrams, flyers, printed forms, graphic prints, reproduction and representations, newsletters and pictures | ACTIVE | — |
| 041 | Arranging and conducting educational colloquiums, conferences or congresses; Providing information about education; publication of on-line electronic books and journals; Practical training in the field of Plasma Protein Replacement Therapies; Publication of texts other than publicity texts; Arranging and conducting seminars, symposiums or workshops in the field of Plasma Protein Replacement Therapies; Teaching in the field of Plasma Protein Replacement Therapies; Educational services, namely, conducting classes, courses and workshops in the field Plasma Protein Replacement Therapies; Instruction services, namely, conducting classes, courses and workshops in the field of Plasma Protein Replacement Therapies | ACTIVE | — |
| 042 | Biological research; Conducting clinical trials for others; Rental of computer software; Electronic data storage; Installation and maintenance of computer software; Quality control of goods and services; Packaging design; Research and development of new products for others; Scientific laboratory services; Scientific research; Conducting feasibility studies in the field of new technologies for Plasma Protein Replacement Therapies; Technology consultation in the field of Plasma Protein Replacement Therapies | ACTIVE | — |
| 044 | Healthcare; Convalescent home services; Hospital services; Medical clinic services; Medical assistance; Medical equipment rental; Nursing home services; Palliative care; Therapy services, namely, Plasma Protein Replacement; Services of a psychologist | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by GRIFOLS WORLDWIDE OPERATIONS LIMITED
- Other trademarks owned by GRIFOLS WORLDWIDE OPERATIONS LIMITED
- Other trademarks owned by GRIFOLS WORLDWIDE OPERATIONS LIMITED
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AMBAR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 17, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 17, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 1, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 1, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 12, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 21, 2020 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jul 17, 2020 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jul 11, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 11, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 11, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 11, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 11, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 6, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 6, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 6, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 6, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 12, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 12, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 10, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 6, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 6, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 6, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 6, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 6, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 6, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 6, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 12, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 12, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 11, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 2, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 1, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 1, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 1, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 29, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 29, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 15, 2019 | NWAP | NEW APPLICATION ENTERED | — |